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Background: Studies have associated betel nut chewing with cancers, metabolic syndrome, cardiovascular
disorders, chronic kidney disease, and proteinuria. This study investigated whether hyperuricemia is associated with
betel nut chewing in men who participated in a health check-up program.
Methods: From hospital records, we identified a total of 11,991 men who participated in the health check-up
program from 2003 to 2009. They were divided into hyperuricemic group and non-hyperuricemic group. Laboratory
tests, medical history, and status of cigarette smoking, alcohol consumption, and betel nut chewing were compared
between the 2 groups. We calculated odds ratio (OR) and 95% confidence interval (CI) of hyperuricemia in association
with betel nut consumption and other factors.
Results: Compared with the non-hyperuricemic group, the hyperuricemic group was slightly older (59.4 vs. 58.6 years)
but less prevalent with betel nut use (11.8 vs. 13.6%, p = 0.003). Multivariable logistic regression analysis showed
that hyperuricemia was negatively associated with betel nut chewing (OR 0.75, 95% CI 0.66-0.84), older age
(OR 0.84, 95% CI 0.77-0.93), and diabetes mellitus (OR 0.57, 95% CI 0.50-0.64). On the other hand, hyperuricemia was
positively associated with body mass index (OR 1.75, 95% CI 1.62-1.90), drinking (OR 1.36, 95% CI 1.25-1.49),
hypertension (OR 1.41, 95% CI 1.30-1.52), mixed hyperlipidemia (OR 1.84, 95% CI 1.33-2.54), chronic kidney disease
(OR 3.28, 95% CI 2.94-3.65), and proteinuria (OR 1.22, 95% CI 1.08-1.38). Smoking, hypercholesterolemia, and
hypertriglyceridemia had no significant association with hyperuricemia.
Conclusion: Our data suggest that betel nut chewing is negatively associated with hyperuricemia.
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Betel nut chewing, a common unhealthy behavior in
Southeast Asian countries, is the fourth most popular
risky habit in the world after smoking, drinking alcohol,
and caffeine consumption. Approximately 600 million
people use this substance globally [1,2]. The prevalence
rate of betel nut chewing in Taiwan has been estimated to
be 12.2% – 16.5% in two large studies [3,4]. Previous stud-
ies have shown that betel nut chewing is related to several
disorders, such as metabolic syndrome [5], cardiovascular* Correspondence: jjeelhsu@yahoo.com.tw
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reproduction in any medium, provided the ordisease (CVD) [6,7], hypertension [8], chronic kidney
disease [9] and proteinuria [10].
Recent epidemiological and clinical studies have also
suggested a close relationship between hyperuricemia and
metabolic syndrome [11], CVD [12], hypertension [13],
and chronic kidney disease [14]. Based on both the revised
and original National Cholesterol Education Program Adult
Treatment Panel (NCEP/ATP) III criteria defined metabolic
syndrome, Choi et al. found that individuals with uric acid
levels of ≥10 mg/dL are 3-fold more likely than those with
serum uric acid levels of <6 mg/dL to be prevalent with
metabolic syndrome [11]. In an Italian study, Verdecchia
et al. reported that study population with a higher serum
uric acid level (>6.2 mg/dL for men and >4.6 mg/dL for
women) have increased risk for cardiovascular events andThis is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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study reported that adults older than 40 with hyperuri-
cemia had an odds ratio (OR) of 3.65 for chronic kidney
disease [14].
Although betel nut chewing and hyperuricemia share a
high degree of similarity in their comorbid conditions,
there is no known research exploring the relationship
between betel nut chewing and hyperuricemia. The asso-
ciation between them deserves further clarification. The
purpose of this study was to investigate the association
between betel nut chewing and hyperuricemia.
Methods
Study subjects
Detailed study design and definitions of variables for this
study have been reported in a previous study [9]. Briefly,
all 34 372 participants attending the Taiwan National
Health Insurance Bureau sponsored health check-up pro-
gram at our hospital from 2003 to 2009 were included in
this study. For 1481 participants with multiple check-ups,
only their first check-up records were used. Participants
(n = 5409) with incomplete records were excluded. The
institutional review board of the Ditmanson Medical
Foundation Chia-Yi Christian Hospital has approved the
present study.
Clinical and demographic variables
All participants were required to complete a self-reported
questionnaire for information on sociodemographic
status, lifestyle, and personal medical history with the
assistance of trained volunteers. Frequency and amount
of smoking, drinking and betel nut chewing “in the
past 6 months” were reported. They reported personal
medical history in regarding to chronic kidney disease,
diabetes mellitus, hypertension, hyperlipidemia, hyper-
uricemia, liver dysfunction, and anemia. The health check
up consisted of anthropometric measurements, and blood
and urine specimens measured with standard automated
technology after 8 hours of overnight fasting, such as sys-
tolic blood pressure (SBP), diastolic blood pressure (DBP),
serum creatinine, total cholesterol, triglycerides, uric acid,
fasting blood glucose, alanine aminotransferase, hemoglobin,
white blood cell count, and urinary biochemical and micro-
scopic examination of sediment. The Modification of
Diet in Renal Disease (MDRD) formula was used to cal-
culate estimated glomerular filtration rate (eGFR) [15].
Definitions of variables
Hyperuricemia was defined as a serum uric acid concen-
tration >7.0 mg/dl for men [16]. Chronic kidney disease
was defined as an eGFR less than 60 ml/min/1.73 m2
calculated using the MDRD formula [15]. Hypertension
was defined as the use of antihypertensive medications,
or SBP >140 mmHg or DBP >90 mmHg [17]. Diabetesmellitus was defined as a fasting plasma glucose level
equal to or over 126 mg/dl or a known history of diabetes
with or without medication [18]. Hyperlipidemia was de-
fined as having a serum total cholesterol level >200 mg/dl,
and/or triglycerides > 150 mg/dl, or a past personal history
of high total cholesterol or triglycerides with or without
medication [19]. Participants were considered to be non-
smokers if they reported that they did not smoke, or as
smokers if they smoked socially, occasionally or irregularly
regardless of the amount in the previous 6 months. They
were considered to be non-chewers if they reported that
they did not consume any betel nut at all, or as chewers
if they consumed betel nut socially, occasionally or
irregularly in the previous 6 months. They were con-
sidered to be non-drinkers if they reported that they
did not consume any alcohol and as drinkers if they
consumed alcohol socially, occasionally or irregularly
regardless of the amount in the previous 6 months.
Proteinuria was defined as having a +/− or heavier protein
response (including + to 4+) in a urine dipstick test.Laboratory measures
Biochemical tests including total cholesterol, triglycerides,
uric acid, and serum creatinine were measured by an auto-
matic analyzer (Hitachi 7170, Hitachi High Technologies
Co. Tokyo, Japan). The reagents for all biochemical tests
were manufactured by Wako Pure Chemical Industries,
Ltd., Japan. Dipstick urine analysis was performed by an
automated chemical analyzer (URISYS 2400, Roche
Diagnostic, Germany).Statistical analysis
Comparative data about the presence or absence of
hyperuricemia were reported as means and standard
deviations or numbers and percentages as appropriate.
Demographics, clinical characteristics and comorbid con-
ditions were analyzed by the Student’s t test for continu-
ous variables and by the x2 test for categorical variables.
To determine the association between betel nut chew-
ing and hyperuricemia, we utilized a univariate and step-
wise multivariate logistic regression models. Covariates
significant at the univariate analysis were included in the
multivariate analysis to further clarify associations be-
tween betel nut chewing and hyperuricemia and other
variables. In addition to examining confounding effects
between betel nut chewing and other variables, we checked
evidence of interaction among them as needed.
All analyses were carried out using the SPSS for
Windows statistical software package version 18 (SPSS
Inc., Chicago, IL, USA). For all difference estimates
and odds ratios, we calculated 95% confidence inter-
vals (95% CIs). P values < 0.05 were considered to be
statistically significant.
Table 1 Demographic and biochemical variables compared between hyperuricemic and non-hyperuricemic groups
Over all Hyperuricemia (−) Hyperuricemia (+)
(n = 11991) (n = 7289, % = 60.8) (n = 4702, % = 39.2) p-value
Age (years) 58.9 ± 12.1 58.6 ± 11.9 59.4 ± 11.3 <0.001*
eGFR (ml/min/1.73 m2) 73.9 ± 16.8 77.4 ± 15.7 68.5 ± 17.2 <0.001*
BMI (Kg/m2) 25.11 ± 3.47 24.7 ± 3.42 25.8 ± 3.43 <0.001*
Systolic BP (mmHg) 133.1 ± 19.7 131.5 ± 19.3 135.6 ± 19.9 <0.001*
DiastolicBP (mmHg) 79.3 ± 12.3 78.1 ± 11.9 81.0 ± 12.6 <0.001*
Serum creatinine (mg/dL) 1.15 ± 0.35 1.09 ± 0.27 1.24 ± 0.43 <0.001*
Serum total cholesterol (mg/dL) 206.5 ± 41.3 204.8 ± 40.4 209.2 ± 42.6 <0.001*
Serum triglyceride (mg/dL) 156.7 ± 166.1 143.0 ± 141.1 177.8 ± 196.8 <0.001*
Serum uric acid (mg/dL) 6.76 ± 1.64 5.74 ± 0.92 8.36 ± 1.17 <0.001*
Fasting plasma glucose (mg/dL) 107.1 ± 40.5 109.5 ± 45.6 103.3 ± 30.6 <0.001*
*p-value < 0.001.
Results are expressed as means ± standard deviation (SD).
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A total of 11,991 male participants (mean age 58.9 ±
12.1 years) were included in the data analysis (Table 1).
Among them, 4,702 (39.2%) individuals were found to
have hyperuricemia with the mean level of 8.36 (SD
1.17) mg/dl. Subjects with hyperuricemia tended to be
older and to have higher mean values of body mass
index (BMI), SBP, DBP, serum creatinine, total cholesterol,
and triglycerides, but lower values of eGFR and fasting
plasma glucose (p <0.001 for all).
Table 2 shows that the prevalence of betel nut chewing
was lower in participants with hyperuricemia than in
participants without hyperuricemia (11.8% vs. 13.6%).Table 2 Personal behaviors and co-morbid conditions compare
Over all Hyperuri
(n = 11991) (n = 7289
Smoker 4448(37.1%) 2725(37.4
Drinker 3892(32.5%) 2251(30.9
Betel Nut Chewer 1545(12.9%) 992(13.6%







Mixed hyperlipidemia 168(1.4%) 72(1.0%)
Proteinuria 1381(11.5%) 724(9.9%)
Results are expressed as n (%).
overweight denotes BMI > = 25.
*p-value < 0.01; **p-value < 0.001.Those with hyperuricemia were more prevalent with
alcohol consumption, chronic kidney disease, hyper-
tension, mixed hyperlipidemia, and proteinuria, but less
likely to be overweight and to have diabetes. The logistic
regression analysis measured ORs for the corresponding
associations are shown in Table 3.
The multivariate logistic regression model showed that
subjects with hyperuricemia had an OR of 0.75 (95%
confidence interval (CI) 0.66-0.84) in association with
betel nut chewing (Table 3). Older men and men with
diabetes were also less likely to be hyperuricemia. Higher
BMI, drinking, hypertension hyperlipidemia, chronic
kidney disease and proteinuria were factors associatedd between hyperuricemic and non-hyperuricemic groups
cemia (−) Hyperuricemia (+)













Table 3 The crude and adjusted odds ratios (aOR) for
hyperuricemia by logistic regression analysis
Crude OR 95% CI aOR 95% CI
Age
≥60 years old 1.12 (1.04-1.20)* 0.84 (0.77-0.92)**
<60 years old 1.00 1.00
BMI
≥25 1.82 (1.69-1.96)** 1.75 (1.62-1.90)**
<25 1.00 1.00
Betel nut chewing
(+) 0.85 (0.76-0.95)* 0.75 (0.66-0.84)**
(−) 1.00 1.00
Smoking
(+) 0.97 (0.90-1.05) 1.02 (0.93-1.10)
(−) 1.00 1.00
Alcohol intake
(+) 1.20 (1.11-1.30)** 1.36 (1.25-1.49)**
(−) 1.00 1.00
Diabetes
(+) 0.71 (0.64-0.79)** 0.57 (0.50-0.64)**
(−) 1.00 1.00
Hypertension
(+) 1.66 (1.55-1.79)** 1.41 (1.30-1.52)**
(−) 1.00 1.00
Hypercholesterolemia
(+) 0.84 (0.57-1.23) 0.83 (0.55-1.24)
(−) 1.00 1.00
Hypertriglyceridemia
(+) 1.14 (0.74-1.76) 1.09 (0.70-1.72)
(−) 1.00 1.00
Mixed hyperlipidemia
(+) 2.09 (1.54-2.84)** 1.84 (1.33-2.54)**
(−) 1.00 1.00
Chronic kidney disease
(+) 3.07 (2.79-3.38)** 3.28 (2.94-3.65)**
(−) 1.00 1.00
Proteinuria
(+) 1.47 (1.32-1.65)** 1.22 (1.08-1.38)*
(−) 1.00 1.00
*p-value < 0.01; **p-value < 0.001.
a: The adjusted odds ratios were measured controlling for age, BMI, betel nut
chewing, smoking, alcohol intake, diabetes, hypertension,
hypercholesterolemia, hypertriglyceridemia, mixed hyperlipidemia, chronic
kidney disease and proteinuria.
Table 4 Odds ratio of hyperuricemia associated with
betel nut chewing by age, body mass index, diabetes
and hypertension
Odds ratio 95% CI P value
Overall a 0.745 (0.658-0.844) <0.001***
Age b
≥60 years old 0.879 (0.697-1.109) 0.277
<60 years old 0.705 (0.607-0.818) <0.001***
BMI b
≥25 0.670 (0.571-0.786) <0.001***
<25 0.874 (0.718-1.065) 0.182
Diabetes b
(+) 0.796 (0.579-1.094) 0.160
(−) 0.833 (0.731-0.95) 0.006**
Hypertension b
(+) 0.799 (0.661-0.967) 0.021*
(−) 0.705 (0.597-0.833) <0.001***
*p-value < 0.05; **p-value < 0.01; ***p-value < 0.001.
a: Multivariate logistic regression analysis conducted with all adjustment
factors, including age, body mass index (BMI), smoking, alcohol intake,
hypertension, diabetes, chronic kidney disease, hypercholesterolemia,
hypertriglyceridemia, mixed-hyperlipidemia, proteinuria.
b: Multivariate logistic regression analysis conducted with the rest of the
variables, in addition to specific variables under stratified conditions as
presence and absence.
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strongest association with hyperuricemia (adjusted OR
3.28, 95% CI 2.94-3.65).Table 4 depicts the association between betel nut chew-
ing and hyperuricemia by stratified levels of age and BMI,
and subjects with and without diabetes and hypertension.
The association was significant for subjects of younger
age, higher BMI, no diabetes and no hypertension.Discussion
In this cross-sectional study, we found that hyperuricemia
is positively associated with BMI, drinking, hypertension,
chronic kidney disease, and proteinuria, but negatively
associated with old age (≧60 y/o), betel nut chewing,
and diabetes mellitus.
To the best of our knowledge, this study was the first
to investigate the association between betel nut chewing
and hyperuricemia. Several mechanisms may provide po-
tential explanations why betel nut chewers have a lower
prevalence of hyperuricemia. The most important chem-
ical components of betel nut are alkaloids [20]. Kanbara
and Seyama [21] found a lower serum uric acid level
with an alkaline diet than with an acidic diet. Uric acid
is more actively reabsorbed with acidic urine than with
alkaline urine. They also found that alkalization of urine
by eating alkaloid food was an effective way to excrete
uric acid via the urine [22]. Further research on uric acid
excretion for betel nut chewers is warranted.
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uricemia and diabetes mellitus is consistent with previous
studies [23-26]. A possible mechanism for this inverse
association may be related to the inhibition of uric acid
reabsorption in the proximal tubules by high glucose
levels [27,28].
A recent research carried out with 14,362 Taiwanese
showed that, for men, values of uric acid decreased as
age increased [29]. The finding is consistent with our
result. Another longitudinal study for men showed that
the incidence of hyperuricemia increased in parallel
with the rise in BMI, with a correlation coefficient of
0.282 (p <0.0001) between serum uric acid levels and
BMI [30]. The results also support our finding of the
positive association between hyperuricemia and BMI.
Our data also showed that drinking alcohol and hyper-
tension were positively associated with hyperuricemia. A
recent meta-analysis of 18 published prospective cohort
studies with 55,607 subjects showed that hyperuricemia
was associated with an increased risk for incidental
hypertension (adjusted risk ratio 1.41, 95% CI 1.23-1.58)
[31]. The overall risk for incidental hypertension in-
creases by 13% per 1 mg/dl increase in serum uric acid
level. Several possible mechanisms for hyperuricemia in
the development of hypertension have been proposed.
Higher uric acid levels could lead to endothelial cell dys-
function via nitric oxide synthetase [32,33] and stimulate
vascular smooth muscle cell proliferation [34]. Uric acid
may directly stimulate the renin-angiotensin system [35,36]
and cause renal afferent arteriolopathy and tubulointerstitial
nephritis, leading to higher blood pressure [36]. Renal
lesions and hypertension are prevented by lowering uric
acid levels with a xanthine oxidase inhibitor or a urico-
suric agent and reversed by an angiotensin-converting
enzyme inhibitor [37].
Previous studies support our findings in associations
between hyperuricemia and mixed hyperlipidemia, chronic
kidney disease and proteinuria [38-43]. Uric acid can
induce pre-glomerular arterial disease, vascular prolif-
eration, renal inflammation, and hypertension via an
activation of renin-angiotensin system and cyclooxygenase-
2, which in turn aggravates renal disease, endothelial dys-
function, hypertension, and cardiovascular disease [44-47].
The stratified analyses shown in Table 4 support our
main outcome. Irrespective of the status in overweight,
diabetes and age, the odds ratios were still all less than
one. In fact, according to Table 3, co-variables with
age ≧ 60, BMI < 25 or presence of diabetes were
already factors for lower hyperuricemia odds, which might
thus keep their ORs less than one but fail to sustain statis-
tical significance in the stratified analyses.
There are several limitations to this study. First, this
study was a cross-sectional study and causality cannot
be concluded. Further prospective cohort studies arenecessary. Second, information about exposure to betel
nut chewing was from self-reported questionnaires, and
obtained from a fixed questionnaire, which included no
status of ex-uses of betel nut, alcohol drinking and
smoking. Potential misclassification of that exposure is
possible without information on ex-uses of these sub-
stances. More detailed histories about the amount of
betel nut chewed, duration, and previous abstinence are
needed. Third, the participants who took the initiative
to undergo the health check-up program in this hospital
may not have represented the general population; they
might have had higher socio-economic status or level
of education, and might have been more alert to the
status of their own health. These factors may have been
sources of selection bias. However, the number of par-
ticipants was large enough to enable us to examine as-
sociations between betel nut chewing and hyperuricemia
after multivariate logistic regression modeling with com-
prehensive adjustments for confounders. The prevalence
of betel nut chewing in our study was also consistent with
two previous large studies in Taiwan [3,4].
Conclusions
Hyperuricemia has an inverse association with betel nut
chewing, diabetes, and old age, while it has a positive as-
sociation with obesity, alcohol consumption, hypertension,
CKD, and proteinuria.
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